Education
About Us
Working with TipRanks
Follow Us
Madhavan Balachandran Insider Profile
4 Followers
Madhavan Balachandran, EVP, Operations at Amgen, holds 31.84K shares in uniQure (Ticker: QURE), holds 27.44K shares in Catalent (Ticker: CTLT), holds 86.52K shares in Amgen (Ticker: AMGN).
Profitable Transactions
5 out of 9 Profitable Transactions
Average Return
-2.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Madhavan Balachandran holds in companies
Most Profitable Insider Trade
The most profitable trade made by Madhavan Balachandran
Madhavan Balachandran's Trading History
Amgen
May 05, 2016
EVP, Operations
Uninformative Buy
―
$28.11M
Catalent
Oct 31, 2023
―
Uninformative Buy
―
$1.74M
uniQure
Jun 21, 2024
Director
Uninformative Buy
―
$389.39K
Replimune Group
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Madhavan Balachandran's performance on stock
You May Also Like
Madhavan Balachandran insider profile FAQ
What is the percentage of profitable transactions made by Madhavan Balachandran?
The percentage of profitable transactions made by Madhavan Balachandran is 56%.
What is the average return per transaction made by Madhavan Balachandran?
The average return per transaction made by Madhavan Balachandran is -2.70%.
What stocks does Madhavan Balachandran hold?
Madhavan Balachandran holds: AMGN, CTLT, QURE, REPL stocks.
What was Madhavan Balachandran’s latest transaction?
Madhavan Balachandran latest transaction was an Uninformative Buy of ―.
What was Madhavan Balachandran's most profitable transaction?
Madhavan Balachandran’s most profitable transaction was an Informative Sell of QURE stock on June 20, 2023. The return on the trade was 76.50%.
What is Madhavan Balachandran's role in Amgen?
Madhavan Balachandran's role in Amgen is EVP, Operations.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.